btw, I think if we gather all orangetom's posts we can turn it into a book.

You are mistaking a culturally instilled set of behaviours for inherent ones.
Some women learn to manipulate and blink their eyes to assert some sort of power, or to achieve their ends because they are taught from a very young age that that is the only acceptable way to do so.
Way out on the west shore of O'ahu. In response to your point about the xerox-ing that is going on, I dont disagree with
you that that is the case. Our culture DOES make it more comfortable to "fit in" to the roles assigned to you by your gender, ethnicity, economic
position, etc. There absolutely is an attempt to penalize individuals who refuse or are unable to mold themselves into this acceptable form.
However, there is also a penalty for compliance. Though one may gain acceptance and approval from others, this is often offset by a deep underlying
unhappiness that you might also note pervades many "civilized" cultures. Look how many people medicate themselves, with psychiatric drugs, pain
killers, alcohol and illegal drugs, excessive spending, immersion in work, too much television, etc. simply to avoid having to face the parts of
themselves that have had to be sacrificed or repressed in order that they conform. We are being pressured to become something other than what we are,
but it isnt entirely effective. Who we really are, inherently, does not go away quietly, it has to be beaten down almost daily. Men and women can be more accepting. I feel it is based on personality although perhaps women are more prone to be more accepting and go with the flow?
Originally posted by stinkhorn
reply to post by Shazam The Unbowed
Look into breast cancer research, look at how much money is wasted on womans breast while men with prostate cancer die by the wayside. F breasts and all the damn walk-a-thons for womans breasts. What about man, woman do not have a prostate, only men do.
Breast cancer is a cancer that starts in the cells of the breast.[1] Worldwide, breast cancer is the second most common type of cancer after lung cancer (10.4% of all cancer incidence, both sexes counted)[2] and the fifth most common cause of cancer death.[3] Worldwide, breast cancer is by far the most common cancer amongst women, with an incidence rate more than twice that of colorectal cancer and cervical cancer and about three times that of lung cancer. However breast cancer mortality worldwide is just 25% greater than that of lung cancer in women.[2] In 2005, breast cancer caused 502,000 deaths worldwide (7% of cancer deaths; almost 1% of all deaths).[3] The number of cases worldwide has significantly increased since the 1970s, a phenomenon partly blamed on modern lifestyles in the Western world.[4][5]
The incidence of breast cancer varies greatly around the world, being lower in less-developed countries and greatest in the more-developed countries. In the twelve world regions, the annual age-standardised incidence rates per 100,000 women are as follows: in Eastern Asia, 18; South Central Asia, 22; sub-Saharan Africa, 22; South-Eastern Asia, 26; North Africa and Western Asia, 28; South and Central America, 42; Eastern Europe, 49; Southern Europe, 56; Northern Europe, 73; Oceania, 74; Western Europe, 78; and in North America, 90.[6]
Women in the United States have the highest incidence rates of breast cancer in the world; 141 among white women and 122 among African American women.[7][8] Among women in the US, breast cancer is the most common cancer and the second-most common cause of cancer death (after lung cancer).[8] Women in the US have a 1 in 8 (12.5%) lifetime chance of developing invasive breast cancer and a 1 in 35 (3%) chance of breast cancer causing their death.[8] In 2007, breast cancer was expected to cause 40,910 deaths in the US (7% of cancer deaths; almost 2% of all deaths).[9]
Source
Prostate cancer is a disease in which cancer develops in the prostate, a gland in the male reproductive system. It occurs when cells of the prostate mutate and begin to multiply out of control. These cells may spread (metastasize) from the prostate to other parts of the body, especially the bones and lymph nodes. Prostate cancer may cause pain, difficulty in urinating, erectile dysfunction and other symptoms.
Rates of prostate cancer vary widely across the world. Although the rates vary widely between countries, it is least common in South and East Asia, more common in Europe, and most common in the United States.[1] According to the American Cancer Society, prostate cancer is least common among Asian men and most common among black men, with figures for white men in-between.[2][3] However, these high rates may be affected by increasing rates of detection.[4]
Prostate cancer develops most frequently in men over fifty. This cancer can occur only in men, as the prostate is exclusively of the male reproductive tract. It is the most common type of cancer in men in the United States, where it is responsible for more male deaths than any other cancer, except lung cancer. In the UK it is also the second most common cause of cancer death after lung cancer. Around 35,000 men in the UK are diagnosed per year; where around 10,000 die of it. However, many men who develop prostate cancer never have symptoms, undergo no therapy, and eventually die of other causes. That is because malignant neoplasms of the prostate are, in most cases, slow-growing, and because most of those affected are over 60. Hence they often die of causes unrelated to the prostate cancer, such as heart/circulatory disease, pneumonia, other unconnected cancers or old age. Many factors, including genetics and diet, have been implicated in the development of prostate cancer.
Prostate cancer is most often discovered by physical examination or by screening blood tests, such as the PSA (prostate specific antigen) test. There is some current concern about the accuracy of the PSA test and its usefulness. Suspected prostate cancer is typically confirmed by removing a piece of the prostate (biopsy) and examining it under a microscope. Further tests, such as X-rays and bone scans, may be performed to determine whether prostate cancer has spread.
Prostate cancer can be treated with surgery, radiation therapy, hormonal therapy, occasionally chemotherapy, proton therapy, cryosurgery, or some combination of these. The age and underlying health of the man as well as the extent of spread, appearance under the microscope, and response of the cancer to initial treatment are important in determining the outcome of the disease. Since prostate cancer is predominantly a disease of older men, many will die of other causes before a slowly advancing prostate cancer can spread or cause symptoms. This makes treatment selection difficult.[5] The decision whether or not to treat localized prostate cancer (a tumor that is contained within the prostate) with curative intent is a patient trade-off between the expected beneficial and harmful effects in terms of patient survival and quality of life.
Source